Pancreatic Cancer Research

ResearcherGuiyang Medical UniversityActive in the last 2 years

Hao Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0613-3798; OpenAlex author ID A5100397000. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 3

  1. HOXC4 promotes proliferation of pancreatic cancer cells by increasing LDHA-mediated glycolysis. Co-author DOI 10.18632/aging.206008↗
  2. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis. Co-author DOI 10.1186/s13046-020-01687-8↗
  3. Reduction of miR-29c enhances pancreatic cancer cell migration and stem cell-like phenotype. Co-author DOI 10.18632/oncotarget.3089↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. She Tian · 1 shared paper, 2024 · strength 0.26
  2. Li Liu · 1 shared paper, 2024 · strength 0.26
  3. Liwen Chen · 1 shared paper, 2024 · strength 0.26
  4. Chengyi Sun · 2 shared papers, 2015–2020 · strength 0.19
  5. Shiyu Chen · 1 shared paper, 2020 · strength 0.13
  6. Zhiwei He · 1 shared paper, 2020 · strength 0.13
  7. Lin Li · 1 shared paper, 2020 · strength 0.13
  8. Meiyuan Chen · 1 shared paper, 2015 · strength 0.06
  9. Chao Yu · 1 shared paper, 2015 · strength 0.06
  10. Jianxin Jiang · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.